WASHINGTON, LONDON and HONG KONG, Jan. 5, 2011 /PRNewswire/ —
SuperNova Diagnostics®, Inc., a privately-held global
diagnostics company for human and non-human health applications,
announced today that Neil J. Campbell, president and CEO, will
present at Biotech Showcase 2011 in conjunction with the J.P.
Morgan Healthcare Conference in San Francisco, CA.
Mr. Campbell’s presentation will be given at the Parc 55 Wyndham
Hotel on Wednesday, January 12, 2011 at 3:30 p.m. PST. “We
are delighted to be presenting at a renowned conference such as
Biotech Showcase,” said Mr. Campbell. “Biotech Showcase and
the J.P. Morgan Healthcare Conference provide a unique opportunity
to present to a diverse group of first-class investors and
executives interested in medical and industrial diagnostics.”
AmpCrystal®, SuperNova Diagnostics’ lead technology and its
multiple product formats, allows for minimally trained individuals
(advanced CLIA-waived) to test for a wide range of protein analytes
and can detect directly un-amplified DNA in humans, animals or
environmental samples.
Time-to-result has been shown in prototypes to be reduced to
minutes on the spot versus the hours or days required when sending
samples to a central laboratory or processing in regional satellite
laboratories. With three integrated capabilities (sample
collector/processor, analytical disposable, and the readout
device), the technology is simpler, more robust, faster and
significantly less expensive than existing POC systems.
Significant advantages of AmpCrystals are direct detection of
samples, simplification of product designs, ability to lower costs
of delivery and broaden range of assay formats from the central
laboratory.
About SuperNova Diagnostics®, Inc.SuperNova® is a
development-stage diagnostics company with a proprietary platform
for conducting diagnostics at the site of interest with
point-of-care in human hea
‘/>”/>
